Related Experiment Video
Updated: Sep 20, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Research progress on the synergistic effect and its mechanisms of antidepressants and antibiotics against resistant
Lihong Ding1, Xia Chen1, Yanli Lv1
1School of Public Health, Gansu University of Chinese Medicine, Lanzhou, 730000, China.
Abstract:
Antimicrobial resistance (AMR) poses a critical global health challenge, driving the urgent need for innovative therapeutic strategies. Antidepressants, traditionally used for major depressive disorders (MDD), have recently attracted attention in non-antibiotic research due to their diverse pharmacological properties, including antimicrobial, antifungal, antiviral, anticancer, antiparasitic, and anti-inflammatory activities. Selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) demonstrated synergistic antimicrobial effects with reduced minimum inhibitory concentrations (MIC) when used in combination with conventional antibiotics, enhancing efficacy against drug-resistant pathogens. Mechanisms underlying this synergy include inhibition of bacterial efflux pumps and disruption of membrane integrity. Despite these promising findings, in vivo studies evaluating antidepressant-antibiotic synergy remain scarce, underscoring the need for further mechanistic and translational research to overcome challenges in clinical application. Overall, antidepressants show significant potential as adjuvants to antibiotics against resistant bacteria, making them promising candidates for combination therapy.
Insights
Antidepressants show potential as novel antimicrobial adjuvants, enhancing antibiotic efficacy against resistant bacteria. Further research is needed to explore their clinical application in combating antimicrobial resistance (AMR).
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Antimicrobial resistance (AMR) is a major global health threat requiring new therapeutic approaches.
- Antidepressants, known for treating major depressive disorders (MDD), exhibit diverse non-antibiotic properties, including antimicrobial activity.
Purpose of the Study:
- To investigate the potential of antidepressants as adjuncts to conventional antibiotics against drug-resistant pathogens.
- To explore the synergistic antimicrobial effects of antidepressants and antibiotics.
Main Methods:
- Review of existing literature on antidepressant pharmacological properties and antimicrobial activities.
- Analysis of studies demonstrating synergistic effects between selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and conventional antibiotics.
Main Results:
- SSRIs and TCAs showed synergistic antimicrobial effects, reducing minimum inhibitory concentrations (MIC) against resistant bacteria.
- Mechanisms include inhibition of bacterial efflux pumps and disruption of bacterial membrane integrity.
Conclusions:
- Antidepressants demonstrate significant potential as adjuvants in combination therapy against resistant bacteria.
- Further in vivo and translational research is crucial to overcome challenges for clinical application.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Development of Antibiotic Resistance
Antibiotic Selection
Antimicrobial Effectiveness
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Microorganisms in Medicine and Therapeutics

